2013 American Transplant Congress
Efficacy and Safety of 3 vs. 6 Months of Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Moderate-Risk (D+/R+) Renal Transplant Recipients Receiving Antilymphocyte Antibody Induction Therapy
Multicenter CMV Pharmacists Collaborative Study Group, Boston
The cytomegalovirus (CMV) donor-positive/recipient-positive (D+/R+) population represents the largest group of at-risk renal transplant recipients (RTR). Practice guidelines on the prevention of CMV recommend prophylaxis…2013 American Transplant Congress
Intracoronary Treatment with VEGF-C/D Inhibitor Enhances Cardiac Allograft Survival and Prevents Chronic Rejection by Regulating Lymphatic Endothelial Cell Activation
Purpose: VEGF-C/D/VEGFR-3 signaling may regulate lymphatic vessel activation and the initiation of alloimmunity after transplantation. However, the mechanisms remain unknown. We investigated the effect of…2013 American Transplant Congress
Mycophenolic Acid (MPA) Dosing: Effect on Efficacy to 4 Years after Kidney Transplantation in the Mycophenolic Acid Observational Renal Transplant (MORE) Study
Maintaining adequate MPA dose may be important to optimize efficacy after kidney transplantation, but prospective long-term data are rare.Methods. MORE was a prospective, observational study…2013 American Transplant Congress
Epigenetic Analysis of the TSDR of FOXP3 Demonstrates That Natural Treg Infiltrate the Cardiac Allograft Already before an Acute Rejection Episode
IntroductionTwo subtypes of FOXP3+ regulatory T cells (Treg) have been identified. Natural (n) Treg originate in the thymus, while antigen specific induced (i) Treg are…2013 American Transplant Congress
How To Handle a Missed or Delayed Dose Intake? A Pharmacokinetic Study of Cyclosporine and Tacrolimus in Renal Transplant Patients
BACKGROUND and OBJECTIVES: Despite the efforts made to optimize adherence, every transplant patient will, at least occasionally, miss doses or take them outside the prescribed…2013 American Transplant Congress
Natural History of the Arteriovenous Access and Risk Factors Affecting Spontaneous Closure after Successful Kidney Transplantation, The
Purpose; After successful kidney transplantation (KT), arteriovenous access (AVA) is neither used nor useful. There are many debates whether to preserve an AVA or to…2013 American Transplant Congress
Does African American (AA) Ethnicity Affect Kidney Transplant Outcomes at Four Years? An Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Study
Prospective data regarding kidney transplant outcomes in AA kidney transplant patients using modern immunosuppressive regimens are limited.Methods: MORE was a 4-year, prospective, observational study at…2013 American Transplant Congress
Cost of Sepsis in a Program Utilizing Indefinite Sulfamethoxazole-Trimethoprim Prophylaxis in Renal Transplant Recipients
Pharmacy, Barnes-Jewish Hospital, St. Louis, MO; Medicine, Washington University, St. Louis, MO
Background: Sepsis represents a significant cost and disease burden to the renal transplant recipient, adversely impacting both patient and graft survival. Sulfamethoxazole-trimethoprim (SMX-TMP) is a…2013 American Transplant Congress
Outcomes of Transplantation for Uncontrolled HCC and Rescue with Marginal Quality Grafts
Surgery, University of Pennsylvania, Philadelphia, PA
Introduction We examined the survival of patients transplanted for progressive hepatocellular cancer (HCC) not controlled with locoregional therapy (LRT) and the impact of the strategy…2013 American Transplant Congress
Economic Impact of Pulsatile Hyothermic Perfusion in an Expanded Criteria Donor Transplant Program. Analysis of the First Year Implementation
INTRODUCTIONKidney transplant (KT) from expanded criteria donors (ECD) have a higher rate of delayed graft function (DGF) that increases postoperative costs because of prolonged hospital…
- « Previous Page
- 1
- …
- 41
- 42
- 43
- 44
- 45
- …
- 178
- Next Page »